Oncology Innovation, real-world data, and precision medicine: Pierre ... Ahead of ASCO 2025, Pierre Fabre charts bold progress in NSCLC with targeted therapies, real-world data, and innovative partnerships
News CRUK scientists find new tool to test lung cancer therapies Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.
Oncology Sponsored 12 Questions with Mimi Huizinga Dr Mimi Huizinga is Vice President, Oncology Medical Affairs, Lung Cancer at AstraZeneca.
Oncology Inside ESMO 2024: Treatments, trials, and top HCPs on social... Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference.
Oncology Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c... mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face